Literature DB >> 7532864

Mnemogenic effects of injecting RA-octil, a CE-inhibitor derivate, systemically or into the basal forebrain.

P Gerhardt1, R U Hasenöhrl, F J Hock, J P Huston.   

Abstract

The aim of this study was to investigate the effects of systemically or intracerebrally administered RA-octil, a derivative of the angiotensin converting enzyme (CE)-inhibitor ramipril, on memory and reinforcement and to compare its effectiveness with that of the neurokinin substance P (SP). In the first experiment systemic post-trial application of RA-octil and SP in the rat enhanced habituation, a learning task which does not require motivational treatments. Unlike SP, injection of RA-octil did not have reinforcing effects as measured with a conditioned place preference task. In the second experiment, a facilitation of inhibitory avoidance learning was obtained by injection of RA-octil or SP unilaterally into the basal forebrain immediately after the learning trial. In contrast, a 5 h delayed injection of RA-octil had no effects on learning. The results demonstrate memory-enhancing effects of RA-octil after systemic application as well as after injection into the basal forebrain. Furthermore, the mnemogenic effects of SP after central and peripheral administration were confirmed. Since RA-octil, although being structurally closely related to CE-inhibitors, does not affect plasma CE, yet exhibits mnemogenic effects, it is possible that "cognition-enhancing" actions of CE-inhibitors are dissociable from their action within the renin-angiotensin system.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7532864     DOI: 10.1007/bf02253534

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  43 in total

1.  Substance P enhancement of inhibitory avoidance learning: mediation by the N-terminal sequence.

Authors:  R U Hasenöhrl; P Gerhardt; J P Huston
Journal:  Peptides       Date:  1990 Jan-Feb       Impact factor: 3.750

2.  Effects of the novel compound, Hoe 065, upon impaired learning and memory in rodents.

Authors:  F J Hock; H J Gerhards; G Wiemer; J Stechl; W Rüger; H Urbach
Journal:  Eur J Pharmacol       Date:  1989-11-14       Impact factor: 4.432

3.  A correlated light and electron microscopic study of identified cholinergic basal forebrain neurons that project to the cortex in the rat.

Authors:  C A Ingham; J P Bolam; B H Wainer; A D Smith
Journal:  J Comp Neurol       Date:  1985-09-08       Impact factor: 3.215

4.  Reinforcing effects of peripherally administered substance P and its C-terminal sequence pGlu6-SP6-11 in the rat.

Authors:  M S Oitzl; R U Hasenöhrl; J P Huston
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

5.  Nootropic effects of ACE inhibitors in mice.

Authors:  C Mondadori; P Etienne
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

6.  The effects of antihypertensive therapy on the quality of life.

Authors:  S H Croog; S Levine; M A Testa; B Brown; C J Bulpitt; C D Jenkins; G L Klerman; G H Williams
Journal:  N Engl J Med       Date:  1986-06-26       Impact factor: 91.245

Review 7.  Chemistry of the inhibitors of the renin-angiotensin system.

Authors:  R Geiger
Journal:  Arzneimittelforschung       Date:  1984

8.  Carboxyl-terminal tripeptidyl hydrolysis of substance P by purified rabbit lung angiotensin-converting enzyme and the potentiation of substance P activity in vivo by captopril and MK-422.

Authors:  M A Cascieri; H G Bull; R A Mumford; A A Patchett; N A Thornberry; T Liang
Journal:  Mol Pharmacol       Date:  1984-03       Impact factor: 4.436

9.  The effects of ACE inhibitors captopril and SQ29,852 in rodent tests of cognition.

Authors:  B Costall; J Coughlan; Z P Horovitz; M E Kelly; R J Naylor; D M Tomkins
Journal:  Pharmacol Biochem Behav       Date:  1989-07       Impact factor: 3.533

10.  Light microscopic evidence for a substance P-containing innervation of the human nucleus basalis of Meynert.

Authors:  T G Beach; H Tago; E G McGeer
Journal:  Brain Res       Date:  1987-04-07       Impact factor: 3.252

View more
  2 in total

Review 1.  Antihypertensive agents for aging patients who are at risk for cognitive dysfunction.

Authors:  Ihab Hajjar; Michelle Keown; Brandy Frost
Journal:  Curr Hypertens Rep       Date:  2005-12       Impact factor: 5.369

Review 2.  Sequence-specific effects of neurokinin substance P on memory, reinforcement, and brain dopamine activity.

Authors:  J P Huston; R U Hasenöhrl; F Boix; P Gerhardt; R K Schwarting
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.